...
【24h】

Neurotoxicity of advanced glycation end-products for cultured cortical neurons.

机译:高级糖基化终产物对培养的皮质神经元的神经毒性。

获取原文
获取原文并翻译 | 示例
           

摘要

The Maillard reaction that leads to the formation of advanced glycation end-products (AGEs) plays an important role in the pathogenesis of angiopathy in diabetic patients and in aging. AGEs are believed also to contribute to the pathology of Alzheimer disease (AD) and other neurodegenerative processes. Incubation of cortical neurons with 5 immunochemically distinct AGEs, designated AGEs-1 to -5, produced a dose-dependent increase in neuronal cell-death, as assessed by MTT assay, Trypan blue and Hoechst 33258 staining. The structural epitope designated AGE-2 was found to have the greatest cytopathic effect and the neurotoxicity of AGE-2 was neutralized by the addition of an anti-AGE-2-specific antibody, but not by other types of anti-AGE antibodies. Distinct classes of AGE structures also have been established to circulate in the blood of individuals with diabetes mellitus and end-stage renal disease treated by hemodialysis (DM-HD). We fractionated serum from normal control and DM-HD patients by gel filtration and identified 2 fractions that contained AGE epitopes-1 to -5 and as well as the defined AGE structure carboxymethyllysine (CML). The addition of these 2 fractions led to the death of cultured neuronal cells and this cytotoxic effect was completely prevented by the addition of the anti-AGE-2-specific antibody. We propose that the structural epitope AGE-2 is an important toxic moiety for neuronal cells.
机译:美拉德反应导致高级糖基化终产物(AGEs)的形成,在糖尿病患者血管病的发病机理和衰老中起着重要作用。据信AGEs也有助于阿尔茨海默氏病(AD)和其他神经退行性过程的病理学。用MTT分析,台盼蓝和Hoechst 33258染色评估,用5种免疫化学上不同的AGEs(称为AGEs-1至-5)孵育皮质神经元会导致神经元细胞死亡的剂量依赖性增加。发现命名为AGE-2的结构表位具有最大的细胞病变作用,并且通过添加抗AGE-2-特异性抗体而不是通过其他类型的抗AGE抗体中和了AGE-2的神经毒性。还建立了不同种类的AGE结构,以在通过血液透析(DM-HD)治疗的糖尿病和终末期肾病患者的血液中循环。我们通过凝胶过滤分离了正常对照和DM-HD患者的血清,并鉴定了2个包含AGE表位-1至-5和定义的AGE结构羧甲基赖氨酸(CML)的馏分。这两个部分的添加导致培养的神经元细胞的死亡,并且通过添加抗AGE-2-特异性抗体完全防止了这种细胞毒性作用。我们提出结构表位AGE-2是神经元细胞的重要毒性部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号